BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16

• Press Releases

  Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD)

  July 7, 2026

   · 

  6 min read
• Press Releases

  Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease

  July 7, 2026

   · 

  4 min read
• Press Releases

  Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535

  July 7, 2026

   · 

  11 min read
• Press Releases

  OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium

  July 7, 2026

   · 

  1 min read
• Press Releases

  Teva to Advance Its Anti-IL-15 Antibody, Designed for Quarterly Dosing, Into Phase 2b Development in Vitiligo, Following Encouraging Phase 1b Results

  July 7, 2026

   · 

  6 min read
• Press Releases

  Endogenex Announces Full Enrollment of the ReCET Clinical Study

  July 7, 2026

   · 

  5 min read
• Press Releases

  Tvardi Therapeutics’ TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement

  July 7, 2026

   · 

  9 min read
• Press Releases

  HMNC Brain Health Announces Publication of Ketabon (KET01) Clinical Trial Results in JAMA Network Open

  July 7, 2026

   · 

  4 min read
• Press Releases

  AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC® 2026

  July 7, 2026

   · 

  4 min read
• Press Releases

  Biovica Appoints Maria Ekdahl as New Chief Financial Officer

  July 7, 2026

   · 

  2 min read